Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277056 · ClinicalTrials.gov registry record
Dysregulated Tyrosine Kinase Signaling in Leukemia
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 30
- Enrollment target
NCT00277056: Clinical Trial study, sponsored by University of New Mexico.
NCT00277056 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00277056 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Dysregulated Tyrosine Kinase Signaling in Leukemia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-10 |
Why NCT00277056 stopped before completion
NCT00277056 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00277056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00277056 about?
NCT00277056 is a clinical study titled "Dysregulated Tyrosine Kinase Signaling in Leukemia". Dysregulated Tyrosine Kinase Signaling in Leukemia
What is the current status of trial NCT00277056?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2002-05. Estimated completion is 2005-10.
Who is sponsoring clinical trial NCT00277056?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia